Cerity Partners’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
58,306
+25,592
+78% +$572K ﹤0.01% 1689
2026
Q1
$555K Buy
32,714
+16,212
+98% +$348K ﹤0.01% 2223
2025
Q4
$424K Sell
16,502
-9,355
-36% -$215K ﹤0.01% 2208
2025
Q3
$556K Sell
25,857
-1,097
-4% -$24.9K ﹤0.01% 1903
2025
Q2
$593K Sell
26,954
-1,927
-7% -$42.3K ﹤0.01% 1775
2025
Q1
$645K Buy
28,881
+15,563
+117% +$335K ﹤0.01% 1634
2024
Q4
$229K Buy
+13,318
New +$207K ﹤0.01% 2172
2024
Q3
Sell
-7,966
Closed -$228K 2586
2024
Q2
$228K Buy
7,966
+252
+3% +$7.59K ﹤0.01% 1965
2024
Q1
$294K Buy
7,714
+515
+7% +$19.5K ﹤0.01% 1876
2023
Q4
$268K Buy
7,199
+235
+3% +$7.89K ﹤0.01% 1574
2023
Q3
$237K Buy
+6,964
New +$263K ﹤0.01% 1230

Other funds holding PGNY

Cerity Partners's PGNY Position: Q2 2026 in Review

Cerity Partners increased its Progyny (PGNY) stake by 78% in Q2 2026, buying an estimated $572K and bringing the position to 58,306 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

Cerity Partners first reported a position in PGNY in Q3 2023 and has held it in 11 quarters since. 284 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Cerity Partners held 58,306 shares of Progyny worth $1.68M as of Q2 2026.
  • Cerity Partners bought 25,592 Progyny shares in Q2 2026, an estimated $572K.
  • Progyny made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1689 holding.
  • Cerity Partners first reported a position in Progyny in Q3 2023 and has held it in 11 quarters since.
  • 284 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.